Answers are grounded in this paper and cite their sources.
The synthesis of BILN 2061, an NS3 protease inhibitor with proven antiviral effect in humans, was accomplished in a convergent manner from four building blocks. The procedure described here was suitable for the preparation of multigram quantities of BILN 2061 for preclinical pharmacological evaluation.
No takes yet. Share an insight, caveat, or question.
Faucher et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: